Related Experiment Video
Updated: Apr 27, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
[Left ventricular function in hypertension without left ventricular hypertrophy: echographic study with modelisation
B Bonnet1, F Jourdan1, G du Cailar1
1Département de médecine interne, hôpital Lapeyronie, CHU de Montpellier, 191, avenue du Doyen-Gaston-Giraud, 34090 Montpellier, France.
Insights
In early hypertension without left ventricular hypertrophy (LVH), the heart adapts to increased blood pressure. Ventricular-arterial coupling remains effective due to enhanced left ventricular (LV) contractility.
Area of Science:
- Cardiovascular Physiology
- Hypertension Research
- Cardiac Mechanics
Background:
- Ventricular-arterial coupling is crucial for left ventricular (LV) performance.
- Uncomplicated hypertension (HT) without LVH presents an early model to study these interactions.
- Assessing LV performance and coupling in early HT is vital for understanding cardiovascular adaptation.
Purpose of the Study:
- To evaluate the impact of uncomplicated HT without LVH on LV performance.
- To analyze ventricular-arterial coupling using simultaneous echocardiography and carotid tonometry.
- To investigate changes in cardiac power output, efficiency, and elastance in early HT.
Main Methods:
- Simultaneous echocardiography and carotid tonometry were used in 10 untreated HT patients and 20 normotensive controls (NT).
- Measurements included LV maximal power (PmaxVG), cardiac power output (CPO), LV efficiency, and aortic/LV elastance (Ea and Ees).
- LV contractility was assessed via PmaxVG calculation and cyclic variations in wall thickness and strain rate.
Main Results:
- Hypertensive patients showed significantly higher systolic blood pressure, LV mass, and pulse wave velocity (PWV) compared to NT.
- Increased cardiac power output (CPO) and aortic elastance (Ea) in HT were compensated by elevated LV elastance (Ees) and LV contractility.
- No significant difference in the Ea/Ees ratio was observed between HT and NT groups.
Conclusions:
- In early-stage HT without LVH, LV performance and ventricular-arterial coupling adapt effectively to elevated afterload.
- This adaptation appears to be driven by an increase in LV contractility.
- These findings highlight the compensatory mechanisms in the cardiovascular system during the initial phases of hypertension.
Abstract:
Because the functional interaction between the LV and arterial systems, termed ventricular-arterial coupling, is recognized as a key determinant of LV performance, the objective of the present study was to assess the impact of uncomplicated HT without LVH on LV performance using simultaneously echocardiography and carotid tonometry. LV maximal power (PmaxVG), cardiac power output (CPO), LV efficiency (CPO/PmaxVG), input aortic and output LV elastance (Ea and Ees) were assessed in 20 normotensive control subjects (NT) and 10 patients with untreated HT. PmaxVG was calculated according to the integral of the product of LV wall stress with strain rate (as an index of gradient velocity). Cyclic variation of wall thickness and SR were measured by speckel-tracking. Ea and Ees were derived and modelized from the pressure-volume curve. No difference in age, BMI and sex ratio was observed between NT and HT. Systolic BP (160±18 vs. 119±10mmHg), LV mass (99±15 vs. 76±12g/m(2)), PWV (9.7±2 vs. 6.9±1m/s) were significantly higher (P<0.01) in HT when compared to NT. In HT increased of CPO and Ea was compensated by an increase of LV (15±4 vs. 12±3%, P<0.02) and Ees (5.5±2 vs. 4.5±1.5mmHg/mL), which are significantly elevated in HT (P<0.05). No difference was observed in Ea/Ees between NT and HT. In conclusion at the early phase of HT, in patients without LVH, LV performance and ventricular-arterial coupling were adapted to post-load elevation. This adaptation may be the result of an increased of LV contractility.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology

